(Q53601181)

16 May 2018

title

Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection. (English)

1 reference

16 May 2018

1 reference

1 reference

2

1 reference

16 May 2018

author name string

Ponni Perumalswami

1

1 reference

16 May 2018

Glen Lutchman

3

1 reference

16 May 2018

Theo Heller

4

1 reference

16 May 2018

Brian Borg

5

1 reference

16 May 2018

Yoon Park

6

1 reference

16 May 2018

T Jake Liang

7

1 reference

16 May 2018

Jay H Hoofnagle

8

1 reference

16 May 2018

Marc G Ghany

9

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 April 2006

1 reference

16 May 2018

published in

Hepatology

1 reference

16 May 2018

volume

43

1 reference

16 May 2018

issue

4

1 reference

16 May 2018

page(s)

780-787

1 reference

16 May 2018

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

cites work

1 reference

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

21 January 2018

1 reference

Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group

21 January 2018

1 reference

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

The long-term pathological evolution of chronic hepatitis C.

21 January 2018

1 reference

7 January 2021

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

1 reference

7 January 2021

Progression of fibrosis in chronic hepatitis C.

1 reference

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

7 January 2021

AGA technical review on nonalcoholic fatty liver disease

1 reference

7 January 2021

The spectrum of liver disease in the general population: lesson from the Dionysos study.

1 reference

7 January 2021

Non-alcoholic fatty liver disease

1 reference

7 January 2021

The pathology of hepatitis C

1 reference

7 January 2021

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

1 reference

7 January 2021

Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

7 January 2021

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

1 reference

7 January 2021

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

7 January 2021

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

1 reference

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

7 January 2021

Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation

1 reference

7 January 2021

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

1 reference

7 January 2021

Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.

1 reference

7 January 2021

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

1 reference

7 January 2021

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

7 January 2021

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease

1 reference

7 January 2021

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

1 reference

7 January 2021

Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis

1 reference

7 January 2021

Apolipoprotein synthesis in nonalcoholic steatohepatitis

1 reference

7 January 2021

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21078

1 reference

16 May 2018

1 reference

16 May 2018